ZA9610582B - Stable, long acting salts of carboxamides for the treatment of joint disease. - Google Patents
Stable, long acting salts of carboxamides for the treatment of joint disease.Info
- Publication number
- ZA9610582B ZA9610582B ZA9610582A ZA9610582A ZA9610582B ZA 9610582 B ZA9610582 B ZA 9610582B ZA 9610582 A ZA9610582 A ZA 9610582A ZA 9610582 A ZA9610582 A ZA 9610582A ZA 9610582 B ZA9610582 B ZA 9610582B
- Authority
- ZA
- South Africa
- Prior art keywords
- carboxamides
- stable
- treatment
- long acting
- joint disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US884495P | 1995-12-19 | 1995-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9610582B true ZA9610582B (en) | 1998-06-17 |
Family
ID=21734019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9610582A ZA9610582B (en) | 1995-12-19 | 1996-12-17 | Stable, long acting salts of carboxamides for the treatment of joint disease. |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU7503496A (en) |
GT (1) | GT199600099A (en) |
MA (1) | MA24045A1 (en) |
TN (1) | TNSN96162A1 (en) |
WO (1) | WO1997022605A1 (en) |
ZA (1) | ZA9610582B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0826685A1 (en) * | 1996-08-21 | 1998-03-04 | Pfizer Inc. | Stable, long acting salts of carboxamides for the treatment of joint disease |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
RO105052B1 (en) * | 1987-02-02 | 1994-12-01 | Pfizer | Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide |
US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
BR9405661A (en) * | 1993-01-22 | 1995-11-21 | Pfizer | 6-Chlorine-5-fluorine-3- (2-tenoyl) -2-oxindole-1-carboxamide lysine salt |
-
1996
- 1996-11-21 AU AU75034/96A patent/AU7503496A/en not_active Abandoned
- 1996-11-21 WO PCT/IB1996/001280 patent/WO1997022605A1/en active Application Filing
- 1996-12-17 ZA ZA9610582A patent/ZA9610582B/en unknown
- 1996-12-18 TN TNTNSN96162A patent/TNSN96162A1/en unknown
- 1996-12-18 MA MA24428A patent/MA24045A1/en unknown
- 1996-12-19 GT GT199600099A patent/GT199600099A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA24045A1 (en) | 1997-07-01 |
TNSN96162A1 (en) | 2005-03-15 |
GT199600099A (en) | 1998-06-12 |
WO1997022605A1 (en) | 1997-06-26 |
AU7503496A (en) | 1997-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2436B1 (en) | Medicament for treating cardiac inflammatory disease. | |
FR2718635B1 (en) | Cervical prosthesis. | |
HU9802422D0 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use | |
ZA991307B (en) | Antibodies against human CD40. | |
HU9603495D0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents | |
ZA968957B (en) | Process for the preparation of dihaloazolopyrimidines. | |
ITTO950104A0 (en) | CATHETER, PARTICULARLY FOR THE TREATMENT OF CARDIAC ARHYTHMIAS. | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
ZA964710B (en) | Novel compounds, the preparation and use thereof. | |
NO981800D0 (en) | Process for the preparation of 1,1,1,3,3-pentafluoropentane | |
ITTO950099A0 (en) | CATHETER, PARTICULARLY FOR THE TREATMENT OF CARDIAC ARHYTHMIAS. | |
ZA983376B (en) | Process for the preparation of flupirtine maleate. | |
ZA966313B (en) | Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them. | |
AU4560299A (en) | Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same | |
PH31643A (en) | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease. | |
AU1496597A (en) | 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's Disease | |
MXPA01003761A (en) | Remedies for ocular diseases. | |
GR3031738T3 (en) | Process for the preparation of 1,1-difluoroethane | |
ZA982255B (en) | Process for the preparation of arylmalonates. | |
ZA9610582B (en) | Stable, long acting salts of carboxamides for the treatment of joint disease. | |
ZA9810403B (en) | New epothilon derivatives, process for their preparation and their pharmaceutical use. | |
HK1010095A1 (en) | Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. | |
NL1000591C2 (en) | Tissue. | |
ZA9610761B (en) | Medical treatment. | |
ZA991215B (en) | Process for the preparation of 1,3-disubstituted 2-nitroguanidines. |